Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals and wellness company, today announced ...

Oxford Lane Capital's valuations are at a lower than usual premium to NAV, making buys more acceptable for CLO investors.

Microsoft shared details on the company's financial results for Q2 FY25 on Wednesday, revealing that gaming revenue was down ...

Levi Strauss beats Q4 expectations but sees drop in shares due to light FY25 guidance impacted by stronger dollar.

Microsoft’s earnings report for Q2 2025 was published at the close of markets today. Microsoft tallied $69.9 billion in ...

Xbox hardware revenue has fallen 29 percent year over year compared to Q2 2024. Microsoft (MSFT) announced the decline in its ...

Embassy Office Parks REIT reported record Q3 FY25 revenue and Net Operating Income (NOI), growing 9% YoY. Strong leasing ...

M. Sees FY25 adjusted free cash flow $17.3B-$18B. Sees FY25 capital expenditures $9.5B. Sees FY25 effective tax rate 24%-26%. Published first on TheFly – the ultimate source for real-time, ...

In Q3 FY25, the banking sector has been impacted by liquidity tightness in the system, having a say on growth in deposits and ...

Maruti Suzuki's Q3 revenue is expected to grow by 17% YoY, with PAT rising 13% YoY, according to estimates from six ...

Arvind SmartSpaces' net consolidated total income stood at Rs 215.47 crore in Q3 FY25, a growth of 149.33 per cent from Rs 86 ...

Lennox (LII) said, for full year 2025, core revenue is anticipated to increase by approximately 2%. Adjusted earnings per share is ...